Hot Pharma Stocks / Ideen / Blockbuster

    Hot Pharma Stocks / Ideen / Blockbuster

    b00n wrote:




    ruädi... der eintrag is noch net so alt.


    wie s grad weiter mag gehn..?

    mit solchem zeug im depot sind absenzen nicht ratsam. Im übrigen hättest vermutl. in dem moment eh nicht können verkaufen.

    Jetzt verkaufen würde ich nicht bzw. tue ich nicht. Wenn an dem laden nur ein bisschen fleisch dran ist sollt da wieder was gehen.. Aktuelle marktkap. is so ca 15 mio.

    onko sure das testkit hat ja immerhin FDA clearence... was is das wert?

    jau ich muss hoffnung haben..lol. werde das genau watchen und vermutl. nochma sehr viele adden.

    Hot Pharma Stocks / Ideen / Blockbuster

    PharmAthene, Inc.

    (Public, AMEX:PIP) Watch this stock




    PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer

    Hot Pharma Stocks / Ideen / Blockbuster

    Quote:

    Quote
    onko sure das testkit hat ja immerhin FDA clearence... was is das wert?


    einiges, wenn die inder es rausreissen. leider kommt sonst kaum positives die letzten monate.

    ich drücke die daumen männer. habe meine shares schon vor länger zeit rausgehauen. manche dinge sind zu unberechenbar, selbst wenn man risiko player ist.


    good luck euch allen.


    by the way ruädi: nicht so viel hinschauen und schwitzen. liegen lassen. sonst wirst du keinen spass haben. denke aber auch, dass nochmal ein 1/4 dollar sichtbar sein wird. dann sogar mehr.

    von OTC an die NASDAQ uplistiting

    Echo Therapeutics Inc

    (Public, OTC:ECTE)


    Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, is pleased to announce that its common shares have been approved for listing on the NASDAQ Capital Market.


    Echo expects its shares to begin trading on NASDAQ on Wednesday, June 29, 2011. The Company will continue to trade under the ticker symbol "ECTE."

    AF

    Generex and TheStreet's biotech blog do have a history.


    Early last year Generex filed a $250 million lawsuit against TheStreet.com and its biotech blogger, after the blogger had played liberally with the facts. Litigation is still ongoing in that suit, and this most recent go-round of salvos certaintly doesn't bring the two sides any closer.


    The fact that GNBT has dipped pretty significantly in the midst of all this just makes it a more attractive entering point for those looking to get in on the longer-term hopes of Oral-lyn, but I'll still be hanging on the sidelines for right now until the reverse split takes place, and then I'll reassess.


    Oral-lyn can be a game-changer if it makes it through the FDA, so if one has patience and some speculative cash to burn, then GNBT might look like a decent buy right about now.


    As for Generex's most recent PR? They got one thing right; they identified author of the post in question for what he is - just another blogger with an opinion.



    tja das war auch adams werk.... da kommt mir RXPC in den sinn....

    Hot Pharma Stocks / Ideen / Blockbuster

    salute vagnum..


    also ich no nid.




    RXPC (RPC)




    Medical Supply Makers Look to Emerging Markets to Stimulate Profits

    Date : 07/05/2011 @ 8:16AM


    Radient Pharmaceuticals has made a heavy push into India over the past year. Dr. Umesh Bhatia, senior advisor for the Onko-Sure for Radient Pharmaceuticals' operations in India recently announced that his group has secured a major new partnership that "should clearly benefit Radient and is expected to impact the company's bottom line." Bharia announced a new joint venture/partnership with Super Religare Laboratories which is the biggest diagnostics lab in India. The lab serves over fifty-thousand doctors in every hospital, in every state in India. Radient's Onko-SureTest Kit is used for the detection and/or monitoring of 14 different types of cancers.




    http://www.bedfordreport.com

    frage..

    increase our authorized shares of Common Stock from 200,000,000 to 750,000,000


    bin mir nicht sicher, wie kann ich das verstehen?

    wird das ein split oder gibts 550,000,000 aktien neu zu zeichnen :?:


    gruess

    Hot Pharma Stocks / Ideen / Blockbuster

    LoadeT wrote:

    Quote
    Läck bisch du aber frühe uf du :)

    um die zit hani mi einisch trüllet hahah


    hehe schön.. derfür bini jetzt scho ufm parkett

    CTIC

    mal eine kleine position gesteckt.


    würde mich wahnsinnig freuen wenn dies der boden war und der turnaround nach dem blutbad gestern hier und heute statt findet. IN


    stop loss bei 1,20 allerdings. kein risiko. noch nicht.